Page 34 - Teddy Whiley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  Avacta Group is developing novel cancer immunotherapies and powerful diagnostics based on its two proprietary platforms - Affimer® biologics and pre|CISION™ tumour targeted chemotherapies.   The Affimer platform is an alternative to antibodies derived from a small human protein. Despite their shortcomings, antibodies currently dominate markets, such as diagnostics and therapeutics, worth in excess of $100bn. Affimer technology has been designed to address many of these negative performance issues, principally: the time taken to generate new antibodies and the r...

DJ Eve Sleep plc: Notice of Investor Presentation Eve Sleep plc (EVE) Eve Sleep plc: Notice of Investor Presentation 11-March-2021 / 10:05 GMT/BST Dissemination of a Regulatory Announcement, transmitted

About ANGLE plc www.angleplc.com   ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLE's proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.   ANGLE's cell separation technology is called the Parsortix ® system, and it enables a liquid biopsy (a simple blood test) to be used to provide the cells of interest to the user in a format suitable for multip...

Press release content from Accesswire. The AP news staff was not involved in its creation. Angle PLC Announces Parsortix-Harvested CTCs Uncover Novel Biomarker February 18, 2021 GMT Parsortix system able to harvest difficult-to-detect mesenchymal CTCs Metastatic biomarker Cyr61 found by researchers in 40% of breast cancer CTCs may be a novel therapeutic target in treating drug-resistant breast cancers GUILDFORD, SURREY / ACCESSWIRE / February 18, 2021 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce that the University Medical Centre Hamburg-Epp...

Investegate announcements from Omega Diagnostics Gp, Director/PDMR Shareholding